|
Avelox In Sodium Chloride 0.8% In Plastic ContainerDrug - Avelox In Sodium Chloride 0.8% In Plastic Container The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; IV (INFUSION)
Active Ingredient(s) -
Moxifloxacin Hydrochloride
Strength -
160MG/100ML
Applicant -
BAYER PHARMS
New Drug Application (NDA) Number -
021277
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 30, 2001
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Bayer Pharmaceuticals Corp
Avelox In Sodium Chloride 0.8% In Plastic Container
Moxam Eq 500mg Base/vial Injectable; Injection
Avelox In Sodium Chloride 0.8% In Plastic Container 160mg/100ml Injectable; Iv (infusion) Oramorph Sr 100mg Tablet, Extended Release; Oral Oramorph Sr 15mg Tablet, Extended Release; Oral Oramorph Sr 30mg Tablet, Extended Release; Oral Oramorph Sr 60mg Tablet, Extended Release; Oral Moxam Eq 10gm Base/vial Injectable; Injection Moxam Eq 1gm Base/vial Injectable; Injection Moxam Eq 250mg Base/vial Injectable; Injection Moxam Eq 2gm Base/vial Injectable; Injection NewDrugInformation |